Agreement, Initial Term

No definition available.

Name:	bhvn_AgreementInitialTerm
Namespace Prefix:	bhvn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the amount of milestone payment to be paid by the company upon the achievement of specified commercial milestones and annual royalty payments based on net sales of products from patents.

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedCommercialMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Milestone Payment To Be Paid By Company Upon Specified Development Milestone Achievement

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedDevelopmentMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Represents the amount of milestone payment to be paid by the company upon the achievement of specified regulatory milestones and annual royalty payments based on net sales of products from patents.

+ References

No definition available.

+ Details

Name:	bhvn_MilestonePaymentToBePaidByCompanyUponSpecifiedRegulatoryMilestoneAchievement
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Minimum Annual Royalty Payment To Be Paid By Company Upon Sale Of Product

+ References

No definition available.

+ Details

Name:	bhvn_MinimumAnnualRoyaltyPaymentToBePaidByCompanyUponSaleOfProduct
Namespace Prefix:	bhvn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479532/912-730-25-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=bhvn_YaleUniversityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=bhvn_YaleCollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=bhvn_YaleMoDEAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License, Acquisitions and Other Agreements - Yale University Agreement (Details) - USD ($)	1 Months Ended		3 Months Ended			9 Months Ended
	Jan. 31, 2021	May 31, 2019	Sep. 30, 2026	Jun. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
License and other agreements
Milestone payment to be paid upon regulatory achievement			$ 711,600,000			$ 711,600,000
Research and development			101,850,000		$ 141,169,000	306,491,000	$ 513,120,000
Development milestone payment to be paid			139,313,000			139,313,000
Commercial milestone payment to be paid			3,187,488,000			3,187,488,000
Yale University \| Yale Arrangement
License and other agreements
Milestone payment to be paid upon regulatory achievement			2,000,000			2,000,000
Minimum annual royalty payment to be paid upon sale of product		$ 1,000,000
Research and development			0		$ 0	0	$ 0
Yale University \| Yale MoDE Agreement
License and other agreements
Minimum annual royalty payment to be paid upon sale of product	$ 1,000,000
Research and development				$ 250,000
Development milestone payment to be paid			1,063,000			1,063,000
Commercial milestone payment to be paid			$ 4,988,000			$ 4,988,000
Initial term of agreement (in years)	20 years